Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 10691 matches for

The 5-year programme award will support research on the DNA repair mechanisms that protect cancer cells from therapy, informing the development of future therapies.

Peter McHugh (right) with Chris Schofield (Department of Chemistry) and Opher Gileadi (Nuffield Department of Medicine)

Tumour Immunology

Tumour Microenvironment

Understanding how to manipulate a tumour's microenvironment and how can use this understanding for therapeutic gain.

DNA Damage & Repair

Similar stories

Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research

Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.

Prof. Ester Hammond and Dr Monica Olcina travel to Warsaw for the first meeting of the EU Horizon funded consortium – HIT-GLIO

Professor Eileen Parkes appointed to lead Oxford’s Experimental Cancer Medicine Centre

Eileen Parkes, Associate Professor in Innate Tumour Immunology in the Department of Oncology, will lead the expansion of the centre’s programmes in early drug development and biomarker research.

Oxford gets £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the city’s two National Institute for Health and Care Research (NIHR) Biomedical Research Centres (BRC).

Cancer Research UK to invest £11 million into cancer science in Oxford

Eileen Parkes secures Clinical Research Career Development Fellowship

Eileen is awarded funding for her research into the tumour microenvironment